posted on 2023-01-20, 11:33authored byWadah Ibrahim, Michael J Wilde, Rebecca Cordell, Matthew Richardson, Dahlia Salman, Robert Free, Bo Zhao, Amisha Singapuri, Beverley Hargadon, Erol Gaillard, Toru Suzuki, Leong Ng, Tim Coats, Paul Thomas, Paul S Monks, Chris Brightling, Neil Greening, Salman Siddiqui
Breath analysis can be a useful noninvasive way to detect disease. Here, Ibrahim et al. studied the volatile organic compound (VOC) signatures associated with acute cardiorespiratory diseases in patients presenting breathlessness. Using two-dimensional gas chromatography and mass spectrometry, the authors found clusters of VOCs associated with acute heart failure, asthma, chronic obstructive pulmonary disease, and pneumonia. These breath biomarkers correlated with blood-based biomarkers. An acute disease VOC score based on a 101-biomarker panel was associated with 2-year all-cause mortality. This study demonstrates how breathomics can help diagnose disease and further our understanding of metabolic subgroups.
Attenuating the effects of hospital-associated disability in exacerbations of Chronic Obstructive Pulmonary Disease using an anabolic intervention: a randomised controlled feasibility study
Research funding was provided by the MRC and EPSRC Stratified Medicine Grant for Molecular Pathology Nodes (Grant No. MR/N005880/1). The research was supported by the National Institute for Health Research (NIHR )Leicester Biomedical Research Centre and NIHR, Leicester Clinical Research Facility, the Leicester Wellcome Trust ISSF (Award No. 204801/Z/16/Z), and the Midlands Asthma and Allergy Research Association(MAARA) to whom we are extremely grateful. N.J.G. is funded by a NIHR post doctoral fellowship (PDF 2017 10 052)
History
Author affiliation
Department of Respiratory Sciences, University of Leicester
Version
AM (Accepted Manuscript)
Published in
Science Translational Medicine
Volume
14
Issue
671
Pagination
eabl5849
Publisher
American Association for the Advancement of Science